From: Factors related to initial treatment for adhesive capsulitis in the medicare population
 | Adhesive Capsulitis Cases (N = 7181) | Watchful Waiting (N = 675) | Injection only (N = 901) | PT only (N = 2937) | Injection + PT (N = 2469) | Surgery (N = 199) | p-value |
---|---|---|---|---|---|---|---|
N (%) | % | % | % | % | % | Â | |
Male | 2570 (35.8) | 37.8 | 38.3 | 34.4 | 35.6 | 41.2 | 0.09* |
Race |  |  |  |  |  |  |  < 0.01* |
 Asian | 122 (1.7) | 2.7 | 1.9 | 1.7 | 1.5 | 0.5 |  |
 Black | 452 (6.3) | 9.0 | 7.2 | 5.9 | 6.0 | 3.0 |  |
 Hispanic | 71 (1.0) | 2.2 | 1.3 | 0.7 | 0.9 | 1.0 |  |
 Other | 165 (2.3) | 2.1 | 1.1 | 2.6 | 2.4 | 2.5 |  |
 White | 6369 (88.7) | 84.0 | 88.5 | 89.1 | 89.2 | 93.0 |  |
Dual eligible for Medicaida | 509 (7.1) | 11.9 | 11.3 | 6.2 | 5.3 | 7.0 |  < 0.0001* |
Mean Age (SD) | 74.8 (6.8) | 76.3 (7.4) | 76.2 (7.1) | 74.9 (6.9) | 74.0 (6.4) | 71.7 (5.1) |  < 0.0001†|
Age Group |  |  |  |  |  |  |  < 0.0001* |
 66–69 | 2262 (31.5) | 26.5 | 24.1 | 31.3 | 34.7 | 47.2 |  |
 70–75 | 2297 (32) | 28.7 | 29.5 | 31.8 | 33.6 | 36.2 |  |
 76–79 | 998 (13.9) | 13.8 | 17.8 | 13.8 | 13.1 | 8.0 |  |
 80–85 | 1055 (14.7) | 19.0 | 18.4 | 14.8 | 12.5 | 7.0 |  |
 86 +  | 574 (8.0) | 11.9 | 10.2 | 8.4 | 6.0 | 1.5 |  |
Region |  |  |  |  |  |  |  < 0.0001* |
 Midwest | 1644 (22.9) | 21.9 | 16.8 | 23.4 | 24.3 | 27.1 |  |
 Northeast | 1450 (20.2) | 21.6 | 19.5 | 22.3 | 18.6 | 6.5 |  |
 South | 2958 (41.2) | 37.3 | 48.8 | 37.0 | 43.5 | 51.3 |  |
 West | 1134 (15.8) | 19.1 | 14.9 | 17.2 | 13.6 | 15.1 |  |
Charlson Comorbidity Index (CCI) |  |  |  |  |  |  |  < 0.001* |
 0 | 2355 (32.8) | 29.3 | 27.5 | 34.1 | 34.2 | 32.2 |  |
 1 | 1572 (21.9) | 19.4 | 21.1 | 21.8 | 22.6 | 26.6 |  |
 2 | 1041 (14.5) | 14.4 | 15.9 | 15.0 | 13.5 | 13.1 |  |
 3 | 876 (12.2) | 14.2 | 13.2 | 11.9 | 11.7 | 12.1 |  |
 4 +  | 1335 (18.6) | 22.7 | 22.3 | 17.3 | 18.0 | 16.1 |  |
Frailty Risk Index (FRI) |  |  |  |  |  |  |  < 0.0001* |
 0 | 4129 (57.5) | 49.9 | 53.5 | 60.2 | 57.5 | 64.8 |  |
 1 | 1809 (25.2) | 27.1 | 24.1 | 24.0 | 26.6 | 24.1 |  |
 2 | 675 (9.4) | 10.1 | 9.5 | 9.0 | 9.9 | 5.5 |  |
 3 +  | 567 (7.9) | 12.9 | 12.9 | 7.0 | 6.0 | 5.5 |  |
Comorbidities | |||||||
 Type 1 Diabetes | 244 (3.4) | 3.3 | 4.6 | 3.2 | 3.2 | 2.5 | 0.17* |
 Type 2 Diabetes | 2132 (29.7) | 30.4 | 30.6 | 28.4 | 30.2 | 35.2 | 0.05* |
 Hyperlipidemia | 3224 (44.9) | 41.5 | 44.3 | 44.1 | 47.0 | 44.7 | 0.08* |
 Hypertension | 3856 (53.7) | 56.4 | 57.2 | 52.8 | 53.3 | 47.2 | 0.02* |
 Thyroid Disorder | 1170 (16.3) | 16.9 | 18.8 | 15.7 | 16.3 | 12.1 | 0.12* |
 Rheumatoid arthritis | 129 (1.8) | 2.7 | 3.8 | 1.4 | 1.5 | 0.5 |  < 0.0001* |
 Gout | 179 (2.5) | 3.0 | 3.3 | 2.1 | 2.5 | 2.0 | 0.27* |
 Parkinson’s Disease | 93 (1.3) | 0.9 | 1.3 | 1.4 | 1.3 | 0.5 | 0.88* |
 Obesity | 57 (0.8) | 0.6 | 0.8 | 0.8 | 0.9 | 2.0 | 0.24* |
Mean Previous Year Medicare Spending (SD)b | $10,183 (20,995) | $12,403 (24,546) | $13,875 (27,669) | $9737 (21,440) | $8967 (16,201) | $7613 (12,064) |  < 0.0001†|